Acuracet® Tablets

Acuracet® (oxycodone HCl/APAP) Tablets

Acuracet is an immediate release opioid analgesic tablet with a proposed indication for relief of moderate-to-severe pain and is designed to introduce limits and impediments to potential abuse via nasal snorting of crushed tablets and intravenous injection of dissolved tablets.  Acuracet contains two active analgesics: the opioid oxycodone HCl and acetaminophen (APAP).

Status

King Pharmaceuticals Research and Development, Inc., a subsidiary of Pfizer, Inc. (Pfizer) our development and commercialization partner licensed Acuracet Tablets in December 2007.

Development Program

Ongoing development, manufacture, and commercialization of Acuracet Tablets is the responsibility of Pfizer.